Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Abbott Laboratories    ABT

ABBOTT LABORATORIES

(ABT)
  Report
Real-time Estimate Quote. Real-time Estimate Cboe BZX - 10/21 10:03:45 am
106.665 USD   -1.56%
08:23aABBOTT LABORATORIES : Raises 2020 Earnings Guidance
DJ
08:12aABBOTT LABORATORIES : 3Q Profit, Sales Rise on Covid-19 Testing
DJ
07:42aAbbott raises annual profit view, signals recovery in medical device sales
RE
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Abbott, Abercrombie & Fitch rise; Coty, Greif fall

share with twitter share with LinkedIn share with facebook
08/27/2020 | 04:21pm EDT

NEW YORK (AP) — Stocks that moved heavily or traded substantially Thursday:

NetApp Inc., up $1.70 to $43.91.

The data storage company handily beat Wall Street's fiscal first-quarter profit and revenue forecasts.

Builders FirstSource Inc., up $2.33 to $30.24.

The building materials company is buying North Carolina-based construction materials supplier BMC Stock Holdings.

Veoneer Inc., up $1.88 to $12.84.

The automotive safety electronics company is collaborating with Qualcomm Technologies on autonomous driving technology.

Abercrombie & Fitch Co., up 90 cents to $12.03.

The clothing and accessories retailer reported a surprising second-quarter profit and beat analyst's revenue forecasts.

Coty Inc., down 31 cents to $3.54.

The owner of Clairol and other cosmetics brands reported a large loss in its fiscal fourth-quarter.

Box Inc., up 95 cents to $20.24.

The digital file management company’s second-quarter earnings beat Wall Street forecasts.

Greif Inc., down $3.57 to $35.83.

The industrial packaging company reported disappointing fiscal third-quarter revenue because of lower demand.

Abbott Laboratories, up $8.10 to $111.29.

The medical device and health care company received U.S. authorization for a 15-minute COVID-19 test.

.

Copyright 2020 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission., source Associated Press News


Stocks mentioned in the article
ChangeLast1st jan.
ABBOTT LABORATORIES -0.33% 107.85 Delayed Quote.24.75%
ABERCROMBIE & FITCH CO. -1.46% 14.805 Delayed Quote.-12.90%
COTY INC. -0.62% 3.2256 Delayed Quote.-71.20%
GREIF, INC. 1.00% 43.54 Delayed Quote.-2.26%
NETAPP, INC. -0.30% 47.125 Delayed Quote.-22.89%
share with twitter share with LinkedIn share with facebook
All news about ABBOTT LABORATORIES
08:23aABBOTT LABORATORIES : Raises 2020 Earnings Guidance
DJ
08:12aABBOTT LABORATORIES : 3Q Profit, Sales Rise on Covid-19 Testing
DJ
07:42aAbbott raises annual profit view, signals recovery in medical device sales
RE
07:39aABBOTT : 3Q Earnings Snapshot
AQ
07:37aABBOTT LABORATORIES : Results of Operations and Financial Condition, Financial S..
AQ
07:34aAbbott quarterly profit rises 28.3% on strong sales of COVID-19 tests
RE
07:31aABBOTT : Reports Third-Quarter 2020 Results; Achieves Strong Double-Digit Earnin..
PR
10/20ABBOTT LABORATORIES : - improved mental and physical condition is directly linke..
AQ
10/20CYBERTHEFT LAWSUIT : ERISA Fiduciary Breach Claims Dismissed Against Plan Sponso..
AQ
10/19ABBOTT LABORATORIES : Improved Mental and Physical Condition is Directly Linked ..
PR
More news
Financials (USD)
Sales 2020 33 210 M - -
Net income 2020 3 949 M - -
Net Debt 2020 11 479 M - -
P/E ratio 2020 48,8x
Yield 2020 1,34%
Capitalization 192 B 192 B -
EV / Sales 2020 6,12x
EV / Sales 2021 5,32x
Nbr of Employees 107 000
Free-Float 88,8%
Chart ABBOTT LABORATORIES
Duration : Period :
Abbott Laboratories Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ABBOTT LABORATORIES
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Average target price 114,71 $
Last Close Price 108,36 $
Spread / Highest target 20,0%
Spread / Average Target 5,86%
Spread / Lowest Target -24,3%
EPS Revisions
Managers
NameTitle
Robert B. Ford President, CEO, Chief Operating Officer & Director
Miles D. White Executive Chairman
Robert E. Funck Chief Financial Officer & Executive Vice President
Roxanne Schuh Austin Independent Director
Samuel C. Scott Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
ABBOTT LABORATORIES24.75%191 855
MEDTRONIC PLC-3.79%146 742
BECTON, DICKINSON AND COMPANY-13.13%68 484
HOYA CORPORATION18.37%43 912
BAXTER INTERNATIONAL INC.-2.97%41 076
DEXCOM, INC.79.40%37 572